Proximity of mutated cells guides the initiation of tumor

NewsGuard 100/100 Score

Scientists have revealed a key factor that influences whether malignant cells will grow to form a tumor, in a new study published today in eLife.

The research combined the use of mouse breast mini-organs with continuous imaging at single-cell resolution to reveal how a tumor becomes established. The results provide insights into the behavior of individual breast cancer cells that could lead to new strategies on how to handle the disease.

Most studies of cancer biology use tissue samples or cells where every cell has faulty mutations that have the potential to form a tumor. This means it is impossible to recreate the very first stages of disease when a single mutated cell overcomes its normal surroundings and develops into cancer.

To study tumor initiation, models need to be established where only a few malignant cells expand in the context of their immediate non-tumor environment. We created a model of breast cancer development where only single cells activate cancer-promoting oncogenes within otherwise healthy breast tissue, and then followed the fate of these cancerous cells."

Ashna Alladin, lead author, postdoctoral researcher in Martin Jechlinger's lab at the European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

To develop their model, the team grew organoids (mini-organs) from mouse breast tissue which recreate the breast structure. They focused on tiny glands within the breast called 'acini'. They then introduced a cancer-promoting gene into a few individual cells within these acini. Some of the cells then had a second gene added, which allowed the cancer-promoting gene to be switched on in the presence of a drug called doxorubicin. This means the team could control which cells had the cancer-promoting gene switched on and were 'transformed' into malignant cells, and record when the cells were transformed.

The cells were also labelled so that they could be individually tracked every 10 minutes for up to four days using a method called light-sheet microscopy. In this way, the team could see exactly which cells went on to initiate a tumor, and which cells did not.

To determine what influences the individual malignant cells to develop a tumor, the researchers designed a computer algorithm that took all the information from the cell images and looked for common features associated with cells that went on to develop tumors. Of all the features tested, only one was significantly linked to the development of a tumor: the number of cells containing the cancer-promoting gene within a tumor. For every additional cell in a cluster that contained a cancer-promoting gene, the odds of this cluster forming a tumor increased nine times.

In line with the modeling approach, when the team looked at the images of the acini, they found that cells that went on to establish tumors at the end of the four-day imaging period could be seen to cluster together at the start of the imaging period. By contrast, the cells that didn't establish tumors were more sparsely located.

"Our results suggest that there is some interaction or signalling that occurs between malignant cells in close proximity that guides the initiation of a tumor within normal tissues," concludes senior author Martin Jechlinger, Group Leader at EMBL. "Our ability to image the fate of these malignant single cells among healthy tissue means that it is now possible to follow tumor initiation, growth and treatment via inhibition by drugs in a realistic model, thereby helping to bridge the gap between model systems and the clinic."

Source:
Journal reference:

Alladin, A., et al. (2020) Mutated cells need to be near each other to kickstart cancer. eLife. doi.org/10.7554/eLife.54066.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Lancet Commission on Breast Cancer: Transforming breast cancer care globally